Suppr超能文献

采用微量天平法和输液分析仪对一款市售智能患者自控镇痛泵进行性能评估研究。

Performance evaluation study of a commercially available smart patient-controlled analgesia pump with the microbalance method and an infusion analyzer.

作者信息

Park Jinsoo, Jung Bongsu

机构信息

R&D Center, MDAPTUS Inc., Korea.

Medical Device Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu, Korea.

出版信息

J Dent Anesth Pain Med. 2022 Apr;22(2):129-143. doi: 10.17245/jdapm.2022.22.2.129. Epub 2022 Mar 25.

Abstract

BACKGROUND

Patient-controlled analgesia (PCA) has been widely used as an effective medical treatment for pain and for postoperative analgesia. However, improper dose errors in intravenous (IV) administration of narcotic analgesics from a PCA infusion pump can cause patient harm. Furthermore, opioid overdose is considered one of the highest risk factors for patients receiving pain medications. Therefore, accurate delivery of opioid analgesics is a critical function of PCA infusion pumps.

METHODS

We designed a microbalance method that consisted of a closed acrylic chamber containing a layer and an oil layer with an electronic balance. A commercially available infusion analyzer (IDA-5, Fluke Co., Everett, WA, USA) was used to measure the accuracy of the infusion flow rate from a commercially available smart PCA infusion pump (PS-1000, UNIMEDICS, Co., Ltd., Seoul, Korea) and compared with the results of the microbalance method. We evaluated the uncertainty of the flow rate measurement using the ISO guide (GUM:1995 part3). The battery life, delay time of the occlusion alarm, and bolus function of the PCA pump were also tested.

RESULTS

The microbalance method was good in the short-term 2 h measurement, and IDA-5 was good in the long-term 24 h measurement. The two measurement systems can complement each other in the case of the measurement time. Regarding battery performance, PS-1000 lasted approximately 5 days in a 1 ml/hr flow rate condition without recharging the battery. The occlusion pressure alarm delays of PS-1000 satisfied the conventional alarm threshold of occlusion pressure (300-800 mmHg). Average accuracy bolus volume was measured as 63%, 95%, and 98.5% with 0.1 ml, 1 ml, and 2 ml bolus volume presets, respectively. A 1 ml/hr flow rate measurement was evaluated as 2.08% of expanded uncertainty, with a 95% confidence level.

CONCLUSION

PS-1000 showed a flow accuracy to be within the infusion pump standard, which is ± 5% of flow accuracy. Occlusion alarm of PS-1000 was quickly transmitted, resulting in better safety for patients receiving IV infusion of opioids. PS-1000 is sufficient for a portable smart PCA infusion pump.

摘要

背景

患者自控镇痛(PCA)已被广泛用作治疗疼痛及术后镇痛的有效医疗手段。然而,PCA输液泵静脉注射麻醉性镇痛药时的剂量错误可能会对患者造成伤害。此外,阿片类药物过量被认为是接受止痛药物治疗患者的最高风险因素之一。因此,精确输送阿片类镇痛药是PCA输液泵的一项关键功能。

方法

我们设计了一种微平衡方法,该方法由一个封闭的丙烯酸腔室组成,腔室内有一层液体和一层油层,并配有电子天平。使用市售的输液分析仪(IDA-5,美国福禄克公司,华盛顿州埃弗雷特)来测量市售智能PCA输液泵(PS-1000,韩国首尔UNIMEDICS有限公司)的输液流速准确性,并与微平衡方法的结果进行比较。我们使用ISO指南(GUM:1995第3部分)评估了流速测量的不确定度。还测试了PCA泵的电池续航时间、堵塞报警延迟时间和推注功能。

结果

微平衡方法在短期2小时测量中表现良好,IDA-5在长期24小时测量中表现良好。在测量时间方面,这两种测量系统可以相互补充。关于电池性能,在1毫升/小时的流速条件下,PS-1000在不充电的情况下可持续约5天。PS-1000的堵塞压力报警延迟满足传统的堵塞压力报警阈值(300-800毫米汞柱)。预设推注体积为0.1毫升、1毫升和2毫升时,平均推注体积准确性分别为63%、95%和98.5%。在95%置信水平下,1毫升/小时的流速测量扩展不确定度评估为2.08%。

结论

PS-1000的流速准确性符合输液泵标准,即流速准确性的±5%。PS-1000的堵塞报警传输迅速,为接受静脉注射阿片类药物的患者提供了更好的安全性。PS-1000作为便携式智能PCA输液泵已足够。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95e8/8995673/24893a5fdb7a/jdapm-22-129-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验